Quantum BioPharma Ltd. (QNTM)
Company Description
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development.
The company operates through two segments, Biopharmaceutical and Strategic Investments.
Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models.
The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices.
In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property.
The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024.
Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
| Country | CA |
| IPO Date | n/a |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | n/a |
| CEO | Zeeshan Saeed |
Contact Details
Address: 55 University Ave. Toronto, ON CA | |
| Website | https://www.quantumbiopharma.com |
Stock Details
| Ticker Symbol | QNTM |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | CA74764Y2050 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Lakshmi P. Kotra BPHARM, Ph.D. | Chief Executive Officer of Lucid & Director |
| Zeeshan Saeed | Founder, Chief Executive Officer, President & Executive Co-Chairman |
| Donal Carroll CPA | Chief Financial Officer |
| Anthony John Durkacz | Founder & Executive Co-Chairman |
| Dr. Andrzej Chruscinski M.D., Ph.D. | Vice President of Clinical & Scientific Affairs |
| Dr. Ashwini Joshi | Director of Pharmaceutical Development |
| Jason D. Sawyer | Head of Finance & Mergers and Acquisitions |
| Maryann Adesso | Corporate Secretary |
| Nathan Coyle CPA | Controller |
| Randell Mack | President of FSD BioSciences |